Genotype-specific neoplastic risk profiles in patients with VHL disease.
Ganner A, Ferrara AM, Sekula P, Schiavi F, Joo JH, Sanso G, Almeida MQ, Knoblauch AL, Gizaw CJ, Krzystolik K, Astheimer SC, Achatz MI, Vieites A, Donegan D, Hundsberger T, Lubinski J, Yildirim Simsir I, Bandgar T, Hasse-Lazar K, Pawlaczek A, Zandee W, Yu K, Kater CE, Rostomyan L, Qi XP, Deutschbein T, Remde H, Dallagnol TN, Yukina M, Baudrand R, Andreescu CE, Kunavisarut T, Ishak ND, Le Guillou Horn X, Shutler G, Jovanovic M, Pęczkowska M, Calissendorf J, Circosta F, Bugalho MJ, Corssmit EPM, Gimm O, Quinkler M, Goldmann A, Watutantrige Fernando S, Zovato S, Santana LS, Freitas-Castro F, Rothermundt C, Zimmermann J, Durmaz A, Aykut A, Vroonen L, Krauss T, Taschner C, Ruf J, Klingler JH, Gläsker S, Lang S, Bucher F, Agostini H, Jilg C, Schultze-Seemann W, Bausch B, Bergfeld A, Rhein K, Uslar T, Concistrè A, Juhlin CC, Casali-da-Rocha JC, Petramala L, Tsoy U, Grineva E, Fang XD, Kotsis F, Schaefer T, Links TP, Makay Ö, Fagundes GFC, Ngeow J, Shah N, Opocher G, Barontini M, Larsson C, Januszewicz A, Viana Lima J, Wohllk N, Letizia C, Donatini G, Maher ER, Beltsevich D, Bancos I, Cybulski C, Walz MK, Köttgen A, Eng C, Neumann HPH, Neumann-Haefelin E.
Ganner A, et al. Among authors: peczkowska m.
Endocr Relat Cancer. 2025 Apr 28;32(5):e240260. doi: 10.1530/ERC-24-0260. Print 2025 May 1.
Endocr Relat Cancer. 2025.
PMID: 40202835